Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Karyopharm Therapeutics Inc (NASDAQ:KPTI)

10.12
Delayed Data
As of Jan 13
 -0.13 / -1.27%
Today’s Change
4.83
Today|||52-Week Range
11.41
+7.66%
Year-to-Date
No recent news for Karyopharm Therapeutics Inc.

Today’s Trading

Previous close10.25
Today’s open10.27
Day’s range10.02 - 10.50
Volume125,465
Average volume (3 months)308,330
Market cap$417.4M
Dividend yield--
Data as of 4:00pm ET, 01/13/2017

Growth & Valuation

Earnings growth (last year)-36.63%
Earnings growth (this year)+15.76%
Earnings growth (next 5 years)-13.68%
Revenue growth (last year)+9.17%
P/E ratioNM
Price/Sales1,887.83
Price/Book1.83

Competitors

 Today’s
change
Today’s
% change
MACKMerrimack Pharmaceut...-0.06-1.83%
AQXPAquinox Pharmaceutic...+0.14+0.79%
CTMXCytomX Therapeutics ...+0.15+1.31%
AVDLAvadel Pharmaceutica...-0.02-0.20%
Data as of 4:00pm ET, 01/13/2017

Financials

Next reporting dateMarch 20, 2017
EPS forecast (this quarter)-$0.62
Annual revenue (last year)$250.0K
Annual profit (last year)-$118.2M
Net profit margin-47,272.40%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
Michael G. Kauffman
President &
Chief Scientific Officer
Sharon Shacham
Corporate headquarters
Newton, Massachusetts

Forecasts


Search for Jobs